A protocol for a single center, randomized, controlled trial comparing the clinical efficacy of 3% diquafosol and 0.1% hyaluronic acid in diabetic patients with dry eye disease

A protocol for a single center, randomized, controlled trial comparing the clinical efficacy of 3% diquafosol and 0.1% hyaluronic acid in diabetic patients with dry eye disease

Abstract Background The global prevalence of diabetes mellitus (DM) continues to rise and 70% of diabetic individuals have dry eye disease (DED) that leads to subsequent abnormalities of the corneal epithelium, corneal nerves, tear film, or corneal endothelium. In addition, persons with diabetes pro...

Full description

Bibliographic Details
Main Authors: Jiayan Chen, Yimeng Chen, Guanghao Qin, Liangzhe Li, Mingze Li, Yuan Cheng, Shuting Zhuang, Zhihui Li, Qing Zhang, Yi Wu, Lanting Yang, Salissou Moutari, Jonathan E. Moore, Ling Xu, Wei He, Sile Yu, Emmanuel Eric Pazo, Xingru He
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Trials
Subjects:
Diabetic dry eye
Dry eye disease
Diquafosol
Hyaluronic acid
Randomized controlled trial
Online Access:https://doi.org/10.1186/s13063-023-07818-8

Internet

https://doi.org/10.1186/s13063-023-07818-8

Similar Items